GILD Operating Cash Flow (Statement)

Gilead Sciences · Operating Cash Flow (Statement)

GILD logo

GILD Operating Cash Flow (Statement)

Latest reported$13.55B
GILD TTM Cash from Operations (-$20.20M → $13.55B)
High-resolution chart · PNG

GILD operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Gilead Sciences Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
13,552,000,000
10,806,000,000
10,019,000,000
9,667,000,000
9,868,000,000
10,366,000,000
10,828,000,000
10,022,000,000
7,468,000,000
8,481,000,000
8,006,000,000
8,404,000,000
9,512,000,000
8,976,000,000
9,072,000,000
9,710,000,000
10,100,000,000
10,614,000,000
11,384,000,000
10,095,000,000
9,092,000,000
9,342,000,000
8,168,000,000
8,832,000,000
9,227,000,000
9,003,000,000
9,144,000,000
8,909,000,000
8,476,000,000
7,707,000,000
8,400,000,000
8,808,000,000
9,290,000,000
11,243,000,000
11,898,000,000
12,631,000,000
14,330,000,000
15,789,000,000
16,994,000,000
18,382,000,000
18,085,000,000
18,758,000,000
20,329,000,000
18,475,667,000
18,423,667,000
16,950,667,000
12,817,667,000
10,523,787,000
7,232,883,000
4,000,887,000
3,104,988,000
3,083,929,000
3,076,201,000
3,413,848,000
3,194,716,000
3,467,095,000
3,618,833,000
3,271,437,000
3,639,010,000
3,385,746,000
3,228,062,000
2,983,886,000
2,833,913,000
3,064,346,000
3,185,455,000
3,109,293,000
3,080,054,000
2,770,808,000
2,422,325,000
2,240,478,000
2,204,659,000
2,070,615,000
1,809,765,000
1,880,416,000
1,765,398,000
1,732,920,000
1,732,480,000
1,486,658,000
1,218,059,000
1,079,000,000
686,841,000
709,749,000
715,080,000
498,679,000
806,716,000
640,397,000
511,378,000
487,243,000
374,917,000
311,871,000
234,607,000
170,242,000
176,698,000
118,466,000
74,409,000
43,491,000
-48,374,000
-80,999,000
-88,132,000
-116,170,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.